Reinventing Cardiovascular Medicine

Developed from years of extensive research and groundbreaking discoveries in the field of bioengineering, the Astyanax approach revolutionizes the transplantation process by providing a new heart for individuals suffering from cardiac disease.

Gone are the days when patients had to endure the agonizing wait until they reached the final stage of heart failure to be eligible for a transplant. Astyanax's cutting-edge technology enables patients to receive life-saving heart transplants at an earlier stage, offering them renewed hope and a chance for improved quality of life.

By intervening earlier in the progression of cardiac disease, Astyanax not only eliminates the need for patients to endure the debilitating symptoms associated with advanced heart failure, but it also eliminates the lifelong dependence on medications and immune suppression.

This groundbreaking development in transplantation medicine signifies a significant shift towards proactive healthcare, where patients can now proactively address their cardiac conditions before they become life-threatening.